Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial
Open Access
- 1 February 2000
- journal article
- Published by Elsevier in Sleep Medicine
- Vol. 1 (1) , 33-39
- https://doi.org/10.1016/s1389-9457(99)00007-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prevalence and pathologic associations of sleep paralysis in the general populationNeurology, 1999
- In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controlsNeurology, 1998
- HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy.Immunogenetics, 1997
- Extensive HLA class II studies in 58 non‐DRB1*15 (DR2) narcoleptic patients with cataplexyTissue Antigens, 1997
- Hypnagogic and Hypnopompic Hallucinations: Pathological Phenomena?The British Journal of Psychiatry, 1996
- NARCOLEPSYNeurologic Clinics, 1996
- Narcolepsy and immunityAdvances in Neuroimmunology, 1995
- DQB1*0602 and DQA1*0102 (DQ1) Are Better Markers Than DR2 for Narcolepsy in Caucasian and Black AmericansSleep, 1994
- Autoimmune hypothesis in narcolepsyNeurophysiologie Clinique, 1993
- HLA antigens in Japanese patients with narcolepsyTissue Antigens, 1984